Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017)
Nephros (NEPH) posted quarterly Non-Current Deffered Revenue of $208000.0 for Q4 2017, down 25.18% year-over-year from $278000.0 in Q4 2016, and down 7.56% quarter-over-quarter from $225000.0 in Q3 2017.
Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017) Analysis & Trends
Nephros' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $208000.0 for Q4 2017.
- In Q4 2017, Non-Current Deffered Revenue fell 25.18% year-over-year to $208000.0; the TTM figure through Dec 2017 stood at $208000.0 (down 25.18% YoY), while the FY2017 annual figure was $208000.0, down 25.18% from the prior year.
- Non-Current Deffered Revenue for Q4 2017 stood at $208000.0, down from $225000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $531000.0 in Q1 2013, with the low at $176000.0 in Q3 2013.
- The 5-year median for Non-Current Deffered Revenue is $338500.0 (2015), against an average of $333833.3.
- The sharpest annual moves came in 2013 and 2014: Non-Current Deffered Revenue tumbled 80.02% in 2013, then jumped 146.59% in 2014.
- Nephros' Non-Current Deffered Revenue stood at $176000.0 in 2013, then surged by 136.93% to $417000.0 in 2014, then slipped by 16.79% to $347000.0 in 2015, then dropped by 19.88% to $278000.0 in 2016, then dropped by 25.18% to $208000.0 in 2017.
- Business Quant data shows NEPH's Non-Current Deffered Revenue at $208000.0 in Q4 2017, $225000.0 in Q3 2017, and $243000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 208,000.00 |
| Sep 30, 2017 | 225,000.00 |
| Jun 30, 2017 | 243,000.00 |
| Mar 31, 2017 | 261,000.00 |
| Dec 31, 2016 | 278,000.00 |
| Sep 30, 2016 | 295,000.00 |
| Jun 30, 2016 | 313,000.00 |
| Mar 31, 2016 | 330,000.00 |
| Dec 31, 2015 | 347,000.00 |
| Sep 30, 2015 | 365,000.00 |
| Jun 30, 2015 | 382,000.00 |
| Mar 31, 2015 | 400,000.00 |
| Dec 31, 2014 | 417,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Jun 30, 2014 | 452,000.00 |
| Sep 30, 2013 | 176,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Mar 31, 2013 | 531,000.00 |
| Dec 31, 2012 | 707,000.00 |
| Sep 30, 2012 | 881,000.00 |